ZEISS Professional Education

Yasha Modi, MD MHS, Carolyn Majcher, OD, FAAO, FORS, Jessica Steen, OD, FAAO, Dipl. ABO

Timely intervention in retinal pathology management is key to preserving patients’ retinas and vision and requires early identification of biomarker changes. As Jessica Steen, OD, FAAO, Dipl. ABO, Carolyn Majcher, OD, FAAO, FORS, and Yasha Modi, MD, MHS, demonstrate, new technologies, such as ocular coherence tomography angiography (OCT-A), offer new insights into the varied ways in which retinal changes can present—including those obscured within the blind spots of other imaging modalities.

Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, Wesdon McCann, OD

Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, and Wesdon McCann, OD, share some case studies which highlight the varied ways that they have used new and traditional structural biomarkers to diagnose and manage glaucoma in their patients.

Wesdon McCann, OD

Join Wesdon McCann, OD as he discusses glaucoma management.

Michael Chaglasian, OD, FAAO

Join Michael Chaglasian, OD, FAAO as he discusses new technology more specifically updates to Zeiss Cirrus 6000 OCT.

Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO, Wesdon McCann, OD

Join Michael Chaglasian, OD, FAAO, Sarah Gleason, OD, FAAO, Dipl. ABO and Wesdon McCann, OD at the Ophthalmic Medical Education Summit during their discussion panel.